Horizon Therapeutics Public Ltd Co

PRINCIPAL FINANCIAL GROUP INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/2/2023

Shares

42,829

Value ($000)

4,955

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/2/2023	4,955	0.0%	42,829	9/30/2023
2023 Q2	8/7/2023	4,491	0.0%	43,666	6/30/2023
2023 Q1	5/9/2023	4,533	0.0%	41,534	3/31/2023
2022 Q4	2/9/2023	95,813	0.1%	841,940	12/31/2022
2022 Q3	11/9/2022	62,452	0.0%	1,009,088	9/30/2022
2022 Q2	8/10/2022	100,679	0.1%	1,262,262	6/30/2022
2022 Q1	5/9/2022	122,933	0.1%	1,168,455	3/31/2022
2021 Q4	2/9/2022	130,561	0.1%	1,211,592	12/31/2021
2021 Q3	11/9/2021	140,303	0.1%	1,280,839	9/30/2021
2021 Q2	8/10/2021	125,335	0.1%	1,338,474	6/30/2021
2021 Q1	5/10/2021	125,837	0.1%	1,367,203	3/31/2021
2020 Q4	2/23/2021	41,780	0.0%	571,149	12/31/2020
2020 Q3	11/6/2020	42,037	0.0%	541,142	9/30/2020
2020 Q2	8/5/2020	35,679	0.0%	641,932	6/30/2020
2020 Q1	5/12/2020	19,198	0.0%	648,164	3/31/2020
2019 Q4	2/5/2020	27,674	0.0%	764,483	12/31/2019